Skip to Content

Join the 'Maxair Autohaler' group to help and get support from people like you.

Maxair Autohaler News

COPD Deaths Down for Most Americans: CDC

Posted 8 Sep 2016 by Drugs.com

THURSDAY, Sept. 8, 2016 – Fewer Americans are dying from chronic obstructive pulmonary disease (COPD), but not black women and the middle-aged, a new government report shows. Between 2000 and 2014, there was a 12 percent overall drop in deaths from the progressive lung disease, according to the U.S. Centers for Disease Control and Prevention. Report co-author Hanyu Ni said the figures aren't unexpected, noting that "the declines in the COPD-related mortality are consistent with declines in the prevalence of current smoking for men and women in the United States." But, Ni added, the study only quantified death rate trends, and didn't look at the reasons behind those trends. Ni is an associate director for science with the CDC's division of vital statistics at the U.S. National Center for Health Statistics. Dr. David Mannino, who's with the University of Kentucky's College of Public ... Read more

Related support groups: Chronic Obstructive Pulmonary Disease, Albuterol, Spiriva, Chronic Obstructive Pulmonary Disease, Maintenance, Ventolin, Fluticasone, Ribavirin, Qvar, Flovent, Budesonide, Epinephrine, Xopenex, Entocort, Ipratropium, ProAir HFA, Tobramycin, Mometasone, EpiPen, Atrovent, Chronic Obstructive Pulmonary Disease, Acute

Asthma Treatments Fail Older Patients More Often: Study

Posted 12 Jun 2015 by Drugs.com

FRIDAY, June 12, 2015 – Asthma treatments, especially inhaled corticosteroids, are less likely to work for older patients, a new study suggests. Researchers looked at 1,200 patients with mild-to-moderate asthma, and found that treatment failure occurred in about 17 percent of those aged 30 and older, compared with about 10 percent of those younger than 30. Lower lung function and having asthma for a longer time were associated with a higher risk of treatment failure. When the researchers focused on specific therapies, they found that treatment failure increased consistently for every year above age 30 among patients who used inhaled corticosteroids. Patients aged 30 and older who used inhaled corticosteroids, either alone or in combination with other therapies, were more than twice as likely to have treatment failure than those younger than 30, the investigators found. Men and women ... Read more

Related support groups: Asthma, Albuterol, Symbicort, Spiriva, Asthma - Maintenance, Ventolin, Advair Diskus, Advair HFA, Asthma - Acute, Combivent, Epinephrine, Xopenex, Theophylline, Dulera, Ipratropium, ProAir HFA, EpiPen, Atrovent, Proventil, Breo Ellipta

Last Two Ozone-Depleting Inhalers Being Phased Out

Posted 29 Oct 2013 by Drugs.com

TUESDAY, Oct. 29 – The last two inhalers to contain chlorofluorocarbons (CFCs), which deplete the ozone layer, will be removed from the market by Dec. 31, the U.S. Food and Drug Administration has announced. That will complete the agency's long-running plan to phase out all of these types of inhalers, to comply with an international treaty that aims to protect the Earth's ozone layer, the FDA said in a news release. Inhalers typically are used to deliver the drug albuterol, which treats asthma and chronic obstructive pulmonary disease (COPD). More than 25 million people suffer from asthma, and another 15 million have been diagnosed with COPD, a serious lung disease that gets worse with time. "CFCs were used as propellants to move the drug out of inhalers so that patients could inhale the medicine," Dr. Badrul Chowdhury, director of the Division of Pulmonary, Allergy and Rheumatology ... Read more

Related support groups: Asthma, Combivent, Maxair Autohaler

FDA to Complete Phase-Out of Chlorofluorocarbon Inhalers

Posted 23 Oct 2013 by Drugs.com

October 23, 2013 – The U.S. Food and Drug Administration will complete its phase-out of all inhaler medical products containing chlorofluorocarbons (CFCs) by Dec. 31, 2013. This effort is to comply with an international treaty to protect the ozone layer by phasing out the worldwide production of numerous substances, including CFCs, which contribute to ozone depletion. While most inhaler products containing CFCs have already been phased out by the FDA, two products currently remain on the market: Combivent Inhalation Aerosol and Maxair Autohaler. However, these products will no longer be available after the end of this year. People with asthma or chronic obstructive pulmonary disease (COPD) who use these inhalers should talk to their health care professional about a prescription for an alternative treatment. Inhalers are critical products for those persons suffering from asthma or ... Read more

Related support groups: Asthma, Combivent, Maxair Autohaler, COPD

Certain COPD Meds Might Raise Heart Risks, Study Says

Posted 20 May 2013 by Drugs.com

MONDAY, May 20 – Long-acting inhaled medications used by millions of people with chronic obstructive pulmonary disease (COPD) may raise the risk of cardiovascular complications among older patients, a new large Canadian study reveals. The finding centers around patients over age 65 who are prescribed long-acting bronchodilators – either anticholinergics (such as Spiriva) or beta-agonists (such as Serevent). Both medications are commonly used to relieve the shortness of breath that characterizes moderate to severe COPD and to improve lung function. The team found that compared with patients who do not use either medication, those using either of these bronchodilators face a notably higher risk for experiencing a cardiac event, such as heart attack or heart failure. "The bad news is that, although everybody's different, there's a chance that by using these long-acting bronchodilators ... Read more

Related support groups: Chronic Obstructive Pulmonary Disease, Albuterol, Spiriva, Chronic Obstructive Pulmonary Disease, Maintenance, Ventolin, Epinephrine, Xopenex, Ipratropium, ProAir HFA, Atrovent, EpiPen, Proventil, Chronic Obstructive Pulmonary Disease, Acute, Salmeterol, Primatene Mist, Adrenalin, Spiriva HandiHaler, Ventolin HFA, Tiotropium, Maxair

Seniors Undertreated for Asthma, and Many Skip Inhalers: Study

Posted 1 May 2012 by Drugs.com

TUESDAY, May 1 – Asthma often is misdiagnosed and undertreated in older people, with only 53 percent of those with asthma using prescribed inhalers, a small new study suggests. The study included 77 people, including people both with and without asthma, who were over age 60. Of those with asthma, 89 percent also had allergies to mold, animals or dust mites. The asthma patients were more likely than those without asthma to have hay fever, arthritis, diabetes, higher levels of pain and poor general health than those without asthma. The study appears in the May issue of the journal Annals of Allergy, Asthma & Immunology. "Those with asthma reported more infections, physician visits and impact on health, yet only half are regularly treating the disease," lead author and allergist Dr. Andrew Smith said in a journal news release. "Patients should regularly carry and take prescribed asthma ... Read more

Related support groups: Asthma, Albuterol, Symbicort, Spiriva, Asthma - Maintenance, Ventolin, Fluticasone, Advair Diskus, Advair HFA, Qvar, Asthma - Acute, Combivent, Flovent, Budesonide, Epinephrine, Xopenex, Dulera, Entocort, Ipratropium, ProAir HFA

Some Schools Don't Let Kids Carry Asthma Inhalers

Posted 27 Apr 2012 by Drugs.com

FRIDAY, April 27 – Although all 50 states have laws that allow children with asthma to carry inhalers at school and 48 states have laws that let youngsters carry epinephrine pens for serious allergies, experts say that some kids are still being denied access to these lifesaving medications during the school day. "Every school district handles this a little bit different, and for those who don't allow children to carry their medications, I think may be due to a lack of knowledge. School officials may not appreciate the risk that having epinephrine pens and inhalers in a locked office, instead of with the child, can pose," said Maureen George, an assistant professor at the University of Pennsylvania School of Nursing in Philadelphia. "Fewer than 200 children die each year from asthma in the U.S. That number is low, but those deaths are preventable. And it's a double tragedy when you lose ... Read more

Related support groups: Asthma, Albuterol, Ventolin, Epinephrine, Xopenex, Anaphylaxis, ProAir HFA, EpiPen, Proventil, Salmeterol, Adrenalin, Primatene Mist, Ventolin HFA, Maxair, Proventil HFA, Terbutaline, Alupent, Brovana, Formoterol, Maxair Autohaler

Rapid Asthma Treatment in ER May Prevent Admission

Posted 6 Apr 2012 by Drugs.com

FRIDAY, April 6 – Rapid treatment with asthma medications seems to help reduce hospitalizations among children with asthma, a new study finds. Canadian researchers analyzed data from 406 children and found that those with moderate or severe asthma attacks who received systemic corticosteroids within 75 minutes of arriving at a hospital emergency department were 16 percent less likely to be admitted to the hospital. Corticosteroids reduce inflammation. The findings illustrate the importance of rapidly identifying and treating children with asthma when they arrive at an emergency department, the researchers said. The study was recently published online in the journal Annals of Emergency Medicine. "We knew that corticosteroids could help avoid hospital admissions and relapses. However, just how delays between emergency department admission and administration of the treatment impacted ... Read more

Related support groups: Asthma, Albuterol, Symbicort, Spiriva, Ventolin, Fluticasone, Advair Diskus, Advair HFA, Qvar, Asthma - Acute, Combivent, Flovent, Budesonide, Epinephrine, Xopenex, Dulera, Entocort, Ipratropium, ProAir HFA, Mometasone

Asthma Meds Likely Safe During Pregnancy: Study

Posted 20 Jan 2012 by Drugs.com

FRIDAY, Jan. 20 – A new study found no statistically significant link between asthma medication use during pregnancy and common birth defects. However, the study did find a positive association between some rare birth defects and mothers with asthma, and potentially with their medication use. But, the researchers couldn't tease out whether the problem was a loss of oxygen from less than well-controlled asthma or an effect of medications. "Worsening asthma is a risk to the mom and the fetus. Hypoxia (a lack of oxygen) we know is a problem for a developing fetus. And, the potential risk they found here is very small. Even if it turns out to be a true increase, the risk is so small. This study raises more questions than it answers," said Dr. Natalie Meirowitz, chief of the division of maternal fetal medicine at Long Island Jewish Medical Center in New Hyde Park, N.Y. What's most ... Read more

Related support groups: Asthma, Albuterol, Symbicort, Spiriva, Asthma - Maintenance, Ventolin, Fluticasone, Advair Diskus, Advair HFA, Qvar, Asthma - Acute, Combivent, Flovent, Budesonide, Epinephrine, Xopenex, Dulera, Entocort, Ipratropium, ProAir HFA

Study Offers Clues to Why Some Don't Benefit From Asthma Drugs

Posted 6 Jan 2012 by Drugs.com

FRIDAY, Jan. 6 – Almost half of patients with mild or moderate asthma may have a different type of disease than those with more severe symptoms, perhaps explaining why common treatments don't work well for them, new research suggests. "We are beginning to understand that different 'flavors' of asthma probably have different molecular mechanisms," said Dr. John Fahy, director of the Airway Clinical Research Center at the University of California, San Francisco. He is the senior author of the new study, published online Friday in the American Journal of Respiratory and Critical Care Medicine. Asthma is a chronic disease involving inflamed airways. As the airways become more swollen, the muscles around them can tighten when something triggers symptoms such as coughing, wheezing and shortness of breath. Current anti-inflammatory treatments target a condition called eosinophilic airway ... Read more

Related support groups: Asthma, Albuterol, Asthma - Maintenance, Triamcinolone, Ventolin, Fluticasone, Qvar, Asthma - Acute, Flovent, Budesonide, Epinephrine, Xopenex, Entocort, ProAir HFA, Mometasone, EpiPen, Proventil, Entocort EC, Salmeterol, Primatene Mist

Use of Asthma Controller Meds on the Rise Among U.S. Kids

Posted 13 Oct 2011 by Drugs.com

THURSDAY, Oct. 13 – The percentage of children with asthma in the United States who use a prescription "controller" medicine has nearly doubled since the late 1990s, a new federal government report finds. The analysis of data from the Medical Expenditure Panel Survey showed that the use of controller drugs by these children increased from 29 percent in 1997-1998 to 58 percent in 2007-2008, according to the latest News and Numbers from the U.S. Agency for Healthcare Research and Quality. Asthma controller drugs include: corticosteroids, which control inflammation and reduce the risk of airway spasms; beta-2-agonists, which make breathing easier; and leukotrienes, which help prevent asthma symptoms from occurring. Use of inhaled corticosteroids among American children with asthma increased from 15.5 percent to 40 percent, use of leukotrienes rose from 3 percent to 34 percent, and use of ... Read more

Related support groups: Asthma, Albuterol, Singulair, Asthma - Maintenance, Triamcinolone, Ventolin, Fluticasone, Qvar, Montelukast, Flovent, Budesonide, Epinephrine, Xopenex, Entocort, ProAir HFA, Mometasone, EpiPen, Proventil, Entocort EC, Salmeterol

New Guidelines for Spotting, Treating COPD Released

Posted 1 Aug 2011 by Drugs.com

MONDAY, Aug. 1 – Four of the world's leading pulmonary associations have issued new guidelines for the diagnosis and treatment of chronic obstructive pulmonary disease, one of the world's leading killers. While the recommendations are based on more recent studies of the disorder, they differ little from previous guidelines and are meant largely to emphasize how critical it is to manage the disease to reduce hospitalizations, exacerbations and deaths, said lead author Dr. Amir Qaseem, director of clinical policy in the medical education division of the American College of Physicians, one of the four sponsoring organizations. "We're repeating the message. Chronic obstructive pulmonary disease is the third leading cause of death and . . . the number keeps going up. In 2007, it was the fifth leading cause of death," said Qaseem. "Many patients are still not getting the appropriate care." ... Read more

Related support groups: Chronic Obstructive Pulmonary Disease, Albuterol, Spiriva, Triamcinolone, Ventolin, Fluticasone, Qvar, Flovent, Budesonide, Epinephrine, Xopenex, Entocort, Ipratropium, ProAir HFA, Mometasone, Atrovent, EpiPen, Proventil, Entocort EC, Salmeterol

Asthma and COPD Inhalers That Contain Ozone-depleting CFCs to be Phased Out; Alternative Treatments Available

Posted 14 Apr 2010 by Drugs.com

Asthma and COPD Inhalers That Contain Ozone-depleting CFCs to be Phased Out; Alternative Treatments Available ROCKVILLE, Md., April 13, 2010--The U.S. Food and Drug Administration today announced, in accordance with longstanding U.S. obligations under the Montreal Protocol on Substances that Deplete the Ozone Layer, seven metered-dose inhalers (MDI) used to treat asthma and chronic obstructive pulmonary disease (COPD) will be gradually removed from the U.S. marketplace. These inhalers contain ozone-depleting chlorofluorocarbons (CFCs), which are propellants that move medication out of the inhaler and into the lungs of patients. Alternative medications that do not contain CFCs are available. The affected products and their phase out schedule include:   Inhaler Medication Last Date to be manufactured, sold or dispensed in U.S. Manufacturer Tilade Inhaler (nedocromil)  June 14, 2 ... Read more

Related support groups: Combivent, Alupent, Maxair Autohaler, Azmacort, Aerobid, Intal Inhaler, Tilade

FDA Medwatch Alert: Maxair Inhaler (pirbuterol acetate inhalation aerosol)

Posted 7 May 2002 by Drugs.com

3M notified healthcare professionals of a voluntary recall of Maxair Inhaler (pirbuterol acetate inhalation aerosol), press and breathe metered dose inhalers. The possibility exists that a Maxair press and breathe aerosol inhaler may stick intermittently and patients may not receive the expected puff of medication. This recall does not affect Maxair Autohaler (pirbuterol acetate inhalation aerosol), a breath-actuated metered dose inhaler.[May 6, 2002 Recall Notice: Pharmacists - 3M][May 6, 2002 Recall Notice: Distributors - 3M][May 6, 2002 Recall Notice: Managed Care - 3M] Read more

Related support groups: Maxair Autohaler

Ask a Question

Further Information

Related Condition Support Groups

Asthma - Acute, Chronic Obstructive Pulmonary Disease, Maintenance, Asthma - Maintenance, Chronic Obstructive Pulmonary Disease, Acute

Maxair Autohaler Patient Information at Drugs.com